IDEAS home Printed from https://ideas.repec.org/a/tec/bioche/ojs6935.html

Legal status of Cannabidiol

Author

Listed:
  • Nicoleta Mirela Blebea

    (Resident year III, specialty Clinical Pharmacy, Ovidius University of Constanţa, Faculty of Pharmacy, Assistance Prof. Dr., Ovidius University of Constanţa, Faculty of Pharmacy, Discipline Pharmacology and Pharmacotherapy)

Abstract

The plant Cannabis sativa L., is a dioecious species belonging to the familie Cannabaceae, natived to Central Asia, with a long history. The first data on the use of this plant date from 2500 BC [1]. In Europe, the plant began to be cultivated between the 14th and 15th centuries, during which time it played an important role in agriculture, helping economic growth. In the Western world, it was increasingly used in nineteenth-century medicine [2]. It was cultivated worldwide in the 18th and 19th centuries as a source of fiber, food and oil. The main ingredients of hemp oils are phytocannabinoids such as cannabidiol (CBD) and terpenoids. The main active compound in the plant is d-9-tetrahydrocannabinol (D-9-THC), which is largely responsible for the psychoactive effects that made Indian hemp famous. While d9-THC has returned to the attention of researchers, other constituents of cannabis, such as CBD, have been studied in recent years for its therapeutic uses [3].Hemp has gained substantial attention in recent years due to the fact that an increasing number of countries legalized Cannabis for medicinal and recreational use. Taking into account the current legislation, there are small differences in the amounts of THC allowed in hemp preparations, ranging from 0.05 to 0.6%. As a result, if the plant contains THC it has a high illicit use and interest, therefore its cultivation is prohibited by national laws [4]. Among the illicit cannabis preparations, we can mention the following: marijuana (a mixture of leaves, flowers and seeds of the hemp plant), hashish (obtained from unfertilized buds) and also oils that can be easily prepared [5].Globally, the use of cannabis-derived preparations in the medical field has a long history. In the twentieth century, consumption became limited until March 30, 1961, when the Cannabis plant and cannabinoids were classified in the Single UN Convention as non-medical substances. In recent years, however, patients' interest in the use of cannabinoids has increased [6].CBD, the main phytocannabinoid obtained from Cannabis sativa, brings new hope to patients suffering from a wide range of conditions: pain, inflammation, epilepsy, sleep disorders, multiple sclerosis, anorexia, schizophrenia, cancer.

Suggested Citation

  • Nicoleta Mirela Blebea, 2022. "Legal status of Cannabidiol," Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990, Technium Science, vol. 3(2), pages 81-86, July.
  • Handle: RePEc:tec:bioche:ojs:6935
    DOI: 10.47577/biochemmed.v3i2.6935
    as

    Download full text from publisher

    File URL: https://techniumscience.com/index.php/biochemmed/article/view/6935
    Download Restriction: no

    File URL: https://libkey.io/10.47577/biochemmed.v3i2.6935?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:tec:bioche:ojs:6935. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Anna Maria Golita (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.